BAK Immune Cell Therapy: Precision Strike Against HLA-I Negative Cancer Cells

BAK therapy (BRM Activated Killer) is an advanced immune cell treatment technology focused on the large-scale activation and proliferation of "CD56-positive cells" within a patient's body. The most significant feature of this therapy is the breadth of its attack, particularly against "invisible" cancer cells that can evade conventional T-cell strikes.

Core Principles of BAK Therapy

Traditional CTL (Cytotoxic T Lymphocyte) and Dendritic Cell (DC) therapies rely heavily on HLA-I (Major Histocompatibility Complex Class I) molecules on the surface of cancer cells for identification. However, many advanced cancer cells evolve mechanisms to reduce or stop the expression of HLA-I, thereby escaping T-cell detection.

BAK therapy overcomes this challenge through the following mechanisms:

1. Activation of CD56-Positive Cells: Primarily proliferates NK cells and γδ T cells, which can identify and kill foreign substances without relying on HLA-I.
2. Comprehensive Attack: In addition to NK and γδ T cells, the culture process includes CTLs and helper T cells, forming a multi-dimensional immune army.
3. High Proliferation Rate: Using the patented serum-free AlyS-BAK culture medium, cell counts can be safely expanded to 10 billion, significantly increasing the offensive firepower.

Patented Technology and Safety

• Patented Culture Medium: The AlyS-BAK culture medium does not contain human or animal serum, completely eliminating the risk of infection from exogenous viruses or bacteria and ensuring high safety during the treatment process.
• Enhanced Offensive Power: Induction by cytokines such as IFN-α and IL-2 significantly enhances the ability of immune cells to penetrate and destroy tumor tissue.

Medical Institution: Akasaka AA Clinic (Tokyo)

BAK therapy is primarily implemented at the "Akasaka AA Clinic," located in a prime area of Minato-ku, Tokyo. The clinic is led by renowned personalized medicine experts and provides comprehensive cancer support and quality-of-life improvements by combining tumor immunotherapy with high-dose Vitamin C and ozone therapy.

[Medical Supporter Compliance Statement] Medical Supporter was formerly certified as a medical visa guarantor by Japan's Ministry of Foreign Affairs and the Ministry of Economy, Trade and Industry (B-066).